TXNDC12 and central nervous system cancer: Furthermore, we found that TXNDC12 was an prognostic factor for 3-year and 5-year survival in glioma patients both in TCGA-RNA-seq (AUC3year = 0.787, AUC5year = 0.755) (Figure 2C) and CGGA-RNA-seq (AUC3year = 0.748, AUC5year = 0.774) (Figure 2F) by ROC curves.